
FBRX
Forte Biosciences Inc.
$21.37
-$1.28(-5.65%)
54
Overall
60
Value
75
Tech
28
Quality
Market Cap
$124.95M
Volume
211.63K
52W Range
$4.90 - $25.97
Target Price
$63.75
Company Overview
| Mkt Cap | $124.95M | Price | $21.37 |
| Volume | 211.63K | Change | -5.65% |
| P/E Ratio | -3.5 | Open | $22.68 |
| Revenue | -- | Prev Close | $22.65 |
| Net Income | $-35.5M | 52W Range | $4.90 - $25.97 |
| Div Yield | N/A | Target | $63.75 |
| Overall | 54 | Value | 60 |
| Quality | 28 | Technical | 75 |
No chart data available
Latest News
Forte Biosciences Reports Increased R&D Costs Amid Clinical Progress
TipRanks Auto-Generated Newsdesk•a month ago
Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT) and Forte Biosciences (FBRX)
Howard Kim•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FBRX | $21.37 | -5.7% | 211.63K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |